NCT01039519 2016-03-10A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)Synta Pharmaceuticals Corp.Phase 2 Completed27 enrolled 22 charts